Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biomaterials ; 303: 122366, 2023 12.
Article in English | MEDLINE | ID: mdl-37948854

ABSTRACT

Osteoarthritis (OA) is a common and complex inflammatory disorder that is frequently compounded by cartilage degradation, synovial inflammation, and osteophyte formation. Damaged chondrocytes release multiple danger mediators that exacerbate synovial inflammation and accelerate the progression to OA. Conventional treatments targeting only a single mediator of OA have failed to achieve a strong therapeutic effect. Addressing the crucial role of multiple danger mediators in OA progression, we prepared polyethylenimine (PEI)-functionalized diselenide-bridged mesoporous silica nanoparticles (MSN-PEI) with cell-free DNA (cfDNA)-binding and anti-oxidative properties. In models of surgery-induced and collagenase-induced arthritis, we showed that these cationic nanoparticles attenuated cartilage degradation and provided strong chondroprotection against joint damage. Mechanistically, multiple target blockades alleviated oxidative stress and dampened cfDNA-induced inflammation by suppressing the M1 polarization of macrophages. This study suggests a beneficial direction for targeting multiple danger mediators in the treatment of intractable arthritis.


Subject(s)
Cell-Free Nucleic Acids , Nanoparticles , Osteoarthritis , Humans , Silicon Dioxide/therapeutic use , Osteoarthritis/drug therapy , Osteoarthritis/metabolism , Inflammation/drug therapy , Inflammation/metabolism , Chondrocytes/metabolism , Nanoparticles/chemistry , Cell-Free Nucleic Acids/metabolism , Cell-Free Nucleic Acids/pharmacology , Cell-Free Nucleic Acids/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...